VYXEOS ((daunorubicin and Cytarabine) Liposome)
VYXEOS is indicated for the treatment of newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in adults and pediatric…
Medications Updated During September 2022, From Newest to Oldest, Page 25
Sirolimus
Sirolimus tablets are an mTOR inhibitor immunosuppressant indicated for the prophylaxis of organ rejection in patients aged >=13 years receiving renal transplants: ○ Patients at…
DOXERCALCIFEROL
Doxercalciferol capsules are indicated for the treatment of secondary hyperparathyroidism in adult patients with Stage 3 or Stage 4 chronic kidney disease (CKD) and adult patients with…
Fenofibrate
Fenofibrate is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as an adjunct to diet: To reduce elevated LDL-C. Total-C. TG and Apo B, and to increase HDL-C in…
Aminocaproic Acid
Aminocaproic acid oral solution is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life-threatening situations, transfusion of appropriate blood products and…